<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4171604/" ref="ordinalpos=3654&amp;ncbi_uid=6643857&amp;link_uid=PMC4171604" image-link="/pmc/articles/PMC4171604/figure/F7/" class="imagepopup">Figure 7. EGF <span class="highlight" style="background-color:">signaling</span> <span class="highlight" style="background-color:">pathway</span> deregulation in DU145 cells after hydralazine exposure.  From: Anti-neoplastic properties of hydralazine in prostate cancer. </a></div><br /><div class="p4l_captionBody">(A) Protein expression heat map of DU145exposed to 40 μM hydralazine (red: protein overexpression; green: protein reduced expression. Experiments were performed in triplicate. (B) Altered cellular pathways identified by DAVID software. EGF receptor pathway showed the lowest p value (10−8). (C) Western Blot validation of disrupted targets of EGF receptor pathway in DU145 cell line upon hydralazine exposure. β-Actin was used as loading control</div></div>